Company
Pharming Group N.V. (PHAR)
Standardized SEC financial data for Pharming Group N.V. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001828316 · NASDAQ · Pharmaceutical Preparations.
Return on equity
0.9%
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cost of revenue | $23.5M | $21.1M | $17.6M | $25.2M | $35.4M | $45.5M |
| Gross profit | $188.6M | $177.7M | $188.1M | $220.1M | $261.8M | $330.6M |
| R&D expense | $38.5M | $70.4M |
Standardized from Pharming Group N.V.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total assets | $418.5M | $397.3M | $425.8M | $462.9M | $400.0M | $500.0M |
| Total liabilities |
Get PHAR data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/PHAR/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/PHAR/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"